{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:18:48Z","timestamp":1788297528901,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020923","name":"I. K. Gujral Punjab Technical University","doi-asserted-by":"publisher","award":["816\/PO\/ReBiBt\/S\/04\/CPCSEA"],"award-info":[{"award-number":["816\/PO\/ReBiBt\/S\/04\/CPCSEA"]}],"id":[{"id":"10.13039\/100020923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020923","name":"I. K. Gujral Punjab Technical University","doi-asserted-by":"publisher","award":["ISFCP\/IAEC\/M16\/2015\/P289"],"award-info":[{"award-number":["ISFCP\/IAEC\/M16\/2015\/P289"]}],"id":[{"id":"10.13039\/100020923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111639","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T02:24:02Z","timestamp":1707445442000},"page":"111639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Neuroprotective effects of Embelin in an ethidium bromide-induced multiple sclerosis in rats: Modulation of p38 MAPK signaling pathway"],"prefix":"10.1016","volume":"129","author":[{"family":"Anika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rimpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111639_b0005","unstructured":"I. Loma, R.H.-C. Neuropharmacology, U. 2011, sclerosis: pathogenesis and treatment, Ingentaconnect.Com. (n.d.), https:\/\/www.ingentaconnect.com\/content\/ben\/cn\/2011\/00000009\/00000003\/art00003 (accessed January 7, 2022)."},{"key":"10.1016\/j.intimp.2024.111639_b0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1148\/radiol.11110601","article-title":"Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging","volume":"262","author":"Yao","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.intimp.2024.111639_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2024.111639_b0020","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/jcm12134274","article-title":"Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges","volume":"12","author":"Khan","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.111639_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104557","article-title":"Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: a three decade study","volume":"71","author":"Moghtaderi","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2024.111639_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1620\/tjem.213.329","article-title":"Chronological changes of CD4+ and CD8+ T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis","volume":"213","author":"Sonobe","year":"2007","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.111639_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2990.1982.tb00305.x","article-title":"Ethidium bromide induced demyelination in the spinal cord of the cat","volume":"8","author":"Blakemore","year":"1982","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.intimp.2024.111639_b0040","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1093\/nar\/gkab143","article-title":"Ethidium bromide interactions with DNA: an exploration of a classic DNA\u2013ligand complex with unbiased molecular dynamics simulations","volume":"49","author":"Galindo-Murillo","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2024.111639_b0045","first-page":"222","article-title":"Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide","volume":"10","author":"Hatami","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.intimp.2024.111639_b0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11011-021-00691-x","article-title":"Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain","volume":"36","author":"Kumar","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.intimp.2024.111639_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00495","article-title":"Embelin, a potent molecule for Alzheimer\u2019s disease: a proof of concept from blood-brain barrier permeability, acetylcholinesterase inhibition and molecular docking studies","volume":"13","author":"Bhuvanendran","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2024.111639_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/ayu.AYU_174_16","article-title":"Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.","volume":"38","author":"Saini","year":"2017","journal-title":"AYU (Int. Q. J. Res. Ayurveda)"},{"key":"10.1016\/j.intimp.2024.111639_b0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1865","article-title":"The many paths to p38 mitogen-activated protein kinase activation in the immune system","volume":"6","author":"Ashwell","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.111639_b0075","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.111639_b0080","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1007\/s12035-016-0182-y","article-title":"Embelin attenuates intracerebroventricular streptozotocin-induced behavioral, biochemical, and neurochemical abnormalities in rats","volume":"54","author":"Arora","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2024.111639_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100051","article-title":"Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats","volume":"1","author":"Sharma","year":"2021","journal-title":"Phytomedicine Plus"},{"key":"10.1016\/j.intimp.2024.111639_b0090","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4103\/1673-5374.270316","article-title":"Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats","volume":"15","author":"Mehan","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2024.111639_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/645197","article-title":"Gait variability and multiple sclerosis","volume":"2013","author":"Socie","year":"2013","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.intimp.2024.111639_b0100","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1177\/1352458512440207","article-title":"Inflammation inhibits GABA transmission in","volume":"18","author":"Rossi","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.intimp.2024.111639_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102290","article-title":"Re-examining the role of TNF in MS pathogenesis and therapy","volume":"9","author":"Fresegna","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.111639_b0110","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.4103\/1673-5374.195273","article-title":"The role of interleukin-6 in central nervous system demyelination","volume":"11","author":"Petkovi\u0107","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2024.111639_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2014.05.009","article-title":"IL1-\u03b2 expression in multiple sclerosis","volume":"343","author":"Maghzi","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.111639_b0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1515\/tnsci-2022-0224","article-title":"Embelin and levodopa combination therapy for improved Parkinson\u2019s disease treatment","volume":"13","author":"Ramachandra","year":"2022","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.intimp.2024.111639_b0125","unstructured":"R. Arora, S.A. Virendra, P.A. Chawla, Mechanistic study on the possible role of embelin in treating neurodegenerative disorders. CNS Neurol. Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS Neurol. Disord.) (2023)."},{"issue":"5","key":"10.1016\/j.intimp.2024.111639_b0130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s12640-021-00401-6","article-title":"Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases","volume":"39","author":"Singh","year":"2021","journal-title":"Neurotox. Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.111639_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2280","article-title":"Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease","volume":"11","author":"Mehmood","year":"2021","journal-title":"Brain Behav."},{"issue":"10","key":"10.1016\/j.intimp.2024.111639_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2302","article-title":"Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis","volume":"11","author":"Mehmood","year":"2021","journal-title":"Brain Behavi."},{"issue":"12","key":"10.1016\/j.intimp.2024.111639_b0145","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/cns.13738","article-title":"BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder","volume":"27","author":"Yin","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2024.111639_b0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cns.13791","article-title":"Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway","volume":"28","author":"Song","year":"2022","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2024.111639_b0155","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1038\/s41598-022-11296-4","article-title":"Association of X-linked TLR-7 gene polymorphism with the risk of knee osteoarthritis: a case\u2013control study","volume":"12","author":"Xi","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2024.111639_b0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/iep.12488","article-title":"mRNA expression profile reveals differentially expressed genes in splenocytes of experimental autoimmune encephalomyelitis model","volume":"104","author":"Mehmood","year":"2023","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.intimp.2024.111639_b0165","first-page":"1","article-title":"Methyl-CpG-binding protein 2 Emerges as a central player in multiple sclerosis and Neuromyelitis optica spectrum disorders","author":"Mehmood","year":"2023","journal-title":"Cell. Mol. Neurobiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:44:40Z","timestamp":1769229880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"alternative-id":["S1567576924001577"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111639","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of Embelin in an ethidium bromide-induced multiple sclerosis in rats: Modulation of p38 MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111639"}}